PET Scan as a Screening Tool for Liver Transplant in Patients With HCC
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
- 试验地点
- 2
- 主要终点
- Overall Survival
研究概览
简要总结
This study aims at testing the utility of PET Scan as a screening tool for liver transplantation in patients with Hepatocellular Carcinoma. Patients being worked up for liver transplant for hepatocellular carcinoma will undergo a PET Scan and will be followed until 2 years after transplantation. At that time survival data will be analysed according to PET Scan results to determine if it can be used to predict outcome.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or female patient over 18 years of age
- •Diagnosis of HCC confirmed by histology if available or by two imaging modalities
- •Able to give written informed consent prior to any study specific screening procedures with the understanding that the patient has the right to withdraw from the study at any time, without prejudice.
排除标准
- •Unable to give consent to the study
- •Unable to undergo a PET Scan
结局指标
主要结局
Overall Survival
时间窗: up to death
The primary objective of the study is to compare, according to PET scan results, the post-transplantation overall survival of patients meeting Milan criteria to those not meeting Milan criteria
次要结局
未报告次要终点
研究者
peter metrakos
Director Multiorgan Transplant Program-MUHC
McGill University Health Centre/Research Institute of the McGill University Health Centre